Unlocking stability: predictors of clinical stability in patients undergoing intermittent levosimendan infusions for advanced heart failure

被引:0
|
作者
Filipa Gerardo, F. [1 ]
Passos, M. [1 ]
Fialho, I. [1 ]
Oliveira Soares, A. [1 ]
Mateus, C. [1 ]
Miranda, I. [1 ]
Lima Lopes, J. [1 ]
Sarmento, M. [1 ]
Roque, D. [1 ]
机构
[1] Hosp Prof Doutor Fernando Fonseca, Amadora, Portugal
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:408 / 408
页数:1
相关论文
共 50 条
  • [41] Preoperative levosimendan in heart failure patients undergoing noncardiac surgery
    Katsaragakis, S.
    Kapralou, A.
    Markogiannakis, H.
    Kofinas, G.
    Theodoraki, E. -M.
    Larentzakis, A.
    Menenakos, E.
    Theodorou, D.
    NETHERLANDS JOURNAL OF MEDICINE, 2008, 66 (04): : 154 - 159
  • [42] Why Levosimendan Improves the Clinical Condition of Patients With Advanced Heart Failure: A Holistic Approach
    Apostolo, Anna
    Vignati, Carlo
    Della Rocca, Michele
    De Martino, Fabiana
    Berna, Giovanni
    Campodonico, Jeness
    Contini, Mauro
    Muratori, Manuela
    Palermo, Pietro
    Mapelli, Massimo
    Alimento, Marina
    Pezzuto, Beatrice
    Agostoni, Piergiuseppe
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (03) : 509 - 514
  • [43] Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis
    Silvetti, Simona
    Nieminen, Markku S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 138 - 143
  • [44] Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period: the LeoDOR Trial
    Polzl, G. Gerhard
    Comin-Colet, J.
    Delgado, J. F.
    Fedele, F.
    Garcia-Gonzales, M. J.
    Gustafsson, F.
    Masip, J. F.
    Papp, Z.
    Stoerk, S.
    Ulmer, H.
    Vrtovec, B.
    Wikstroem, G.
    Altenberger, J. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 331 - 331
  • [45] Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain
    Manito Lorite, Nicolas
    Rubio-Rodriguez, Dario
    Gonzalez Costello, Jose
    Diez Lopez, Carles
    Enjuanes Grau, Cristina
    Segovia-Cubero, Javier
    Delgado Jimenez, Juan Francisco
    Campo Sien, Carlos
    Rubio-Terres, Carlos
    Comin-Colet, Josep
    REVISTA ESPANOLA DE CARDIOLOGIA, 2020, 73 (05): : 361 - 367
  • [46] Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta-analysis of randomized trials
    Silvetti, Simona
    Belletti, Alessandro
    Fontana, Antonella
    Pollesello, Piero
    ESC HEART FAILURE, 2017, 4 (04): : 595 - 604
  • [47] Clinical experience with ambulatory perfusion of levosimendan in an advanced heart failure unit
    Pamies-Besora, J.
    Moliner-Abos, C.
    Fluvia, P.
    Rivas-Lasarte, M.
    Alvarez-Garcia, J.
    Mirabet, S.
    Lopez, L.
    Brossa, V.
    Roig, E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 420 - 420
  • [48] Predictors of treatment failure and clinical stability in patients with community acquired pneumonia
    Morley, Deirdre
    Torres, Antoni
    Cilloniz, Catia
    Martin-Loeches, Ignacio
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (22)
  • [49] Ambulatory intermittent levosimendan in patients with advanced heart failure not candidates for advanced therapies is effective to improve functional capacity and reduce hospital admissions
    Beltran Troncoso, P.
    Mena Sebastia, E.
    Faraudo Garcia, M.
    Freixa Pamies, R.
    Guri Baiget, O.
    Camprecios Crespo, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 174 - 175
  • [50] Levosimendan in outpatients with advanced heart failure: Single-center experience of 200 intermittent perfusions
    Reis, Joao Ferreira
    Goncalves, Antonio Valentim
    Moreira, Rita Ilhao
    da Silva, Tiago Pereira
    Timoteo, Ana Teresa
    Pombo, Delmira
    Carvalho, Tiago
    Correia, Catarina
    Santos, Claudia
    Ferreira, Rui Cruz
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2023, 42 (04) : 335 - 343